Exquisite antitumour response to trastuzumab in a patient with no evidence of Ras-Raf-MAPK and PI3K-Akt pathways activation

Breast

Volumn 13, Issue 4, 2004, Pages 347-349

  Mano, Max S ^a   Awada, A ^a   Minisini, A ^a   Durbecq, V ^a   Di Leo, A ^a   Piccart, M ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

Breast cancer; Epithelial growth factor; Raf kinase inhibitors; Survival pathways; Trastuzumab

Indexed keywords

ANTHRACYCLINE; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE INHIBITOR; RAF PROTEIN; RAS PROTEIN; SORAFENIB; TRASTUZUMAB; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG RESPONSE; DRUG SENSITIVITY; ENZYME ACTIVATION; FEMALE; HUMAN; LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME;

EID: 4444248291     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2003.11.009     Document Type: Article

References (5)

1. Cohen S. Carpenter G. King L. Epidermal growth factor-receptor-protein kinase interactions: co-purification of receptor and epidermal growth factor-enhanced phosphorylation activity J Biol Chem 255 10 1980 4834-4842
2. Mendelsohn J. Targeting the epidermal growth factor receptor for cancer therapy J Clin Oncol 20 18 Suppl 2002 1S-13S
3. Yakes F.M. Chinratanalab W. Ritter C.A. King W. Seelig S. Arteaga C.L. Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt is required for antibody-mediated effects on p27, cyclin D1, and antitumor action Cancer Res 62 14 2002 4132-4141
4. Strumberg D, Awada A, Piccart M, et al. Final report of the phase I clinical program of the novel raf kinase inhibitor BAY 43-9006 in patients with refractory solid tumors. Proc Am Soc Clin Oncol 2003;22: p. 203 (abstr 813).
5. Moelling K. Schad K. Bosse M. Zimmermann S. Schweneker M. Regulation of Raf-Akt cross-talk J Biol Chem 277 34 2002 31099-31106